✨Doc Stars – hosted by JJ Ullrich 🎙️
Dr. Thomas Slavin on MRD, ctDNA & Transforming Cancer Care. Minimal residual disease (MRD) testing and circulating tumor DNA (ctDNA) are reshaping cancer care—from early detection to real-time treatment decisions. Triple-board-certified physician-scientist Dr. Thomas Slavin (Quest Diagnostics / Haystack Oncology) explains how blood-based diagnostics can spare patients unnecessary chemotherapy and bring precision oncology to more people, faster.
🔗 Connect with Dr. Thomas Slavin:
Quest Diagnostics → questdiagnostics.com
Haystack Oncology → haystackmrd.com
DocPod it.
📱 Hear Health → docpod.co | @docpodhealth
🌐 DocPod — The Healthcare Channel
⚙️ DocPod On Call AI: Curates & Connects
